Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA)
Clinical trial NCT01105936 · COMPLETED
Trial details
- NCT number
- NCT01105936
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-08-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.